You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic Canada does not review or control the content on the other website, and is not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site not be licensed for sale in Canada.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
By choosing to accept, you acknowledge that you are a Certified Healthcare Professional.
Transcatheter valve technology represents a less invasive means for treating heart valve disease and is designed to allow physicians to deliver replacement valves via a catheter through the body's cardiovascular system, thus eliminating the need to open the chest.
The CoreValveTM EvolutTM R Transcatheter Aortic Valve (TAVR) system was built on the proven foundation of the CoreValve platform. It was designed specifically to meet the clinical needs of patients with severe aortic stenosis at extreme or high risk for surgical valve replacement.
The Evolut R system provides control during deployment for accurate positioning with the ability to recapture and reposition the valve. It is the only system indicated down to 5.0mm vessel diameter—that's the lowest profile for all valve sizes in the market today–and treats an annulus range from 17*/18-26 mm.
Deliberate design improvements to the Evolut R valve contribute to an enhanced sealing with a more conformable frame, resulting in exceptional hemodynamics.
*Measurement for TAV–in–SAV only.